http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32451474

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 169
issn 2330-1910
issueIdentifier 3
pageRange 159-169
publicationName American journal of clinical and experimental urology
startingPage 159
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cf5b9d5995507abc870f68cd20a978d7
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bc454af61456f8e8c1ae80bcdda2f1dd
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_593f1996cb4a36654f9df0566cae90dd
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_96399cf467d751009df55ca07098ae89
bibliographicCitation Xian P, Ge D, Wu VJ, Patel A, Tang WW, Wu X, Zhang K, Li L, You Z. PD-L1 instead of PD-1 status is associated with the clinical features in human primary prostate tumors. Am J Clin Exp Urol. 2019;7(3):159–69. PMID: 31317055; PMCID: PMC6627547.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_725d050e8d55b0e2381bb0de68600f0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a264b8f870692fe3e17d50c1db5df9d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85c2b49962e3b0890b1c5f96c1d3b3b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f21ab51f516d50b96f940a5316feb4e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2be8a8f70e1cd037086e79c0c4a917f8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50d26110546744d1cb085b1bb80d3019
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_892f4e1e17a11c1d969b730a01e1eb28
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23cbfb7d0ff8d7514ff2ed68f6e92e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7e065211805408b4c95a9d86d4e4c29
date 2019
identifier https://pubmed.ncbi.nlm.nih.gov/31317055
https://pubmed.ncbi.nlm.nih.gov/PMC6627547
isPartOf https://portal.issn.org/resource/ISSN/2330-1910
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42776
language English
source https://pubmed.ncbi.nlm.nih.gov/
title PD-L1 instead of PD-1 status is associated with the clinical features in human primary prostate tumors
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8382
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.77
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8

Total number of triples: 38.